Abstract
Developments in bioprocessing technology play an important role for overcoming challenges in cardiac tissue engineering. To this end, our laboratory has developed a novel rotary perfused bioreactor for supporting three-dimensional cardiac tissue engineering. The dynamic culture environments provided by our novel perfused rotary bioreactor and/or the high-aspect rotating vessel produced constructs with higher viability and significantly higher cell numbers (up to 4 × 105 cells/bead) than static tissue culture flasks. Furthermore, cells in the perfused rotary bioreactor showed earlier gene expressions of cardiac troponin-T, α- and β-myosin heavy chains with higher percentages of cardiac troponin-I-positive cells and better uniformity of sacromeric α-actinin expression. A dynamic and perfused environment, as provided by this bioreactor, provides a superior culture performance in cardiac differentiation for embryonic stem cells particularly for larger 3D constructs.








Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Abbreviations
- HARV:
-
High-aspect rotating vessel
- ρ :
-
Density of fluid
- υ :
-
Viscosity of fluid
- D mi :
-
Diffusion coefficient of glucose
- Y i :
-
Mass fraction of glucose
- J i :
-
Diffusion flux of glucose
- R i :
-
Net production rate of glucose
- S i :
-
User defined source from neighboring grids of glucose
References
Akins RE, Schroedl NA, Gonda SR, Hartzell CR (1997) Neonatal rat heart cells cultured in simulated microgravity. In Vitro Cell Dev Biol Anim 33:337–343
Amsden B, Turner N (1999) Diffusion characteristics of calcium alginate gels. Biotechnol Bioeng 65:605–610
Antin PB, Bates MA, Zhang W, Garriock RJ, Yatskievych TA (2002) Precocious expression of cardiac troponin T in early chick embryos is independent of bone morphogenetic protein signaling. Dev Dyn 225:135–141
Azarin SM, Palecek SP (2010) Development of scalable culture systems for human embryonic stem cells. Biochem Eng J 48:378–384
Bauwens C, Yin T, Dang S, Peerani R, Zandstra PW (2005) Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng 90:452–461
Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G (2002) Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 8:175–188
Chen HC, Hu YC (2006) Bioreactors for tissue engineering. Biotechnol Lett 28:1415–1423
Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW (2004) Controlled, scalable embryonic stem cell differentiation culture. Stem Cells 22:275–282
Gerecht-Nir S, Cohen S, Itskovitz-Eldor J (2004) Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 86:493–502
Hecker L, Khait L, Radnoti D, Birla R (2009) Novel bench-top perfusion system improves functional performance of bioengineered heart muscle. J Biosci Bioeng 107:183–190
Huang Y, Jia X, Bai K, Gong X, Fan Y (2010) Effect of fluid shear stress on cardiomyogenic differentiation of rat bone marrow mesenchymal stem cells. Arch Med Res 41:497–505
Hunt NC, Grover LM (2010) Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32:733–742
Hwang YS, Randle WL, Bielby RC, Polak JM, Mantalaris A (2006) Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with HepG2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng 12:1381–1392
Lake J, Rathjen J, Remiszewski J, Rathjen PD (2000) Reversible programming of pluripotent cell differentiation. J Cell Sci 113:555–566
Lim M, Teo A, Mantalaris A (2012) Hydrodynamics and bioprocess considerations in designing bioreactors for cardiac tissue engineering. J Regen Med Tissue Eng 1:4
Ma CYJ, Kumar R, Xu XY, Mantalaris A (2007) A combined fluid dynamics, mass transport and cell growth model for a three-dimensional perfused bioreactor for tissue engineering of haematopoietic cells. Biochem Eng J 35:1–11
McDevitt T, Palecek S (2008) Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol 19:527–533
Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111:344–358
Niebruegge S, Nehring A, Bär H, Schroeder M, Zweigerdt R, Lehmann J (2008) Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A 14:1591–1601
Niebruegge S, Bauwens C, Peerani R, Thavandiran N et al (2009) Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 102:493–507
Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, Freed LE, Vunjak-Novakovic G (2004) Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 286:H507–H516
Rungarunlert S, Klincumhom N, Bock I, Nemes C, Techakumphu M, Pirity MK, Dinnyes A (2011) Enhanced cardiac differentiation of mouse embryonic stem cells by use of the slow-turning, lateral vessel (STLV) bioreactor. Biotechnol Lett 33(8):1565–1573
Sargent CY, Berguig GY, McDevitt TC (2009) Cardiomyogenic differentiation of embryoid bodies is promoted by rotary orbital suspension culture. Tissue Eng Part A 15:331–342
Sargent CY, Berguig GY, Kinney MA, Hiatt LA, Carpenedo RL, Berson RE, McDevitt TC (2010) Hydrodynamic modulation of embryonic stem cell differentiation by rotary orbital suspension culture. Biotechnol Bioeng 105:611–626
Schroeder M, Niebruegge S, Werner A, Willbold E et al (2005) Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng 92:920–933
Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A (2008) The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29:3946–3952
Tanaka H, Matsumura M, Veliky I (1984) Diffusion characteristics of substrates in Ca-alginate gel beads. Biotechnol Bioeng 26:53–58
Ueno S, Weidinger G, Osugi T, Kohn AD et al (2007) Biphasic role for Wnt/-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 104:9685–9690
Wong SSY, Bernstein HS (2010) Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Regen Med 5:763–775
Wu X, Ding S, Ding Q, Gray NS, Schultz PG (2004) Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126:1590–1591
Yau WWY, Tang MK, Chen E, Wong IWC, Lee HSS, Lee KKH (2011) Cardiogenol C can induce mouse hair bulge progenitor cells to transdifferentiate into cardiomyocyte-like cells. Proteome Sci 9:3
Yeo D, Kyparissides A, Cha JM, Aguilar-Gallardo C et al (2013) Improving embryonic stem cell expansion through the combination of perfusion and bioprocess model design. PLoS ONE. doi:10.1371/journal.pone.0081728
Yirme G, Amit M, Laevsky I, Osenberg S, Itskovitz-Eldor J (2008) Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev 17:1227–1242
Zimmermann WH, Schneiderbanger K, Schubert P, Didie M et al (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223–230
Acknowledgments
The authors would like to acknowledge the financial support provided by Nanyang Technological University (NTU)-Imperial joint PhD program and Singapore National Research Foundation (NRF) under the NRF-Technion Research Thrust (NRF-Technion/2012-SG#04).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Teo, A., Mantalaris, A., Song, K. et al. A novel perfused rotary bioreactor for cardiomyogenesis of embryonic stem cells. Biotechnol Lett 36, 947–960 (2014). https://doi.org/10.1007/s10529-014-1456-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-014-1456-y

